<DOC>
	<DOCNO>NCT01698437</DOCNO>
	<brief_summary>Focused Ultrasound Focused ultrasound attractive method non-invasive thermal ablation soft tissue tumor . Treatment begin acquire series MR image target organ . The physician identifies target volume MR image delineate treatment contour image . Therapy planning software calculate parameter require effectively treat define target volume . During treatment ultrasound transducer generate focus ultrasound energy focal point , call sonication . The sonication raise tissue temperature within well-defined region degree , cause thermal coagulation . MR image acquire sonication provide quantitative , real-time temperature map target area confirm location sonication size coagulated region . The sonication process repeat multiple adjacent point cover entire prescribed treatment volume .</brief_summary>
	<brief_title>Magnetic Resonance ( MR ) Guided Focused Ultrasound Treatment Brain Tumors</brief_title>
	<detailed_description />
	<mesh_term>Brain Neoplasms</mesh_term>
	<criteria>1 . Male female age 18 year old give inform write consent participate study . Females reproductive age provide negative serum pregnancy test . 2 . Patients primary diagnosis ( biopsy proven ) malignant glioma recurrent glioma , accept conventional tumor resection conventional tumor resection indicate accord neurosurgeon charge neurooncology colloquium Kantonsspital Aarau . Or : Patients supratentorial brain metastasis malignant tumor , accept conventional tumor resection conventional tumor resection indicate accord neurosurgeon charge neurooncology colloquium Kantonsspital Aarau . 3 . The portion tumor treat one intervention le 3.0 cm diameter , correspond volume ca . 14 cc . If total size tumor large 3.0 cm diameter eventual complementing ablation perform 2 week first treatment . 4 . The tumor treat clearly define well distinguish surround brain tissue . 5 . The border target tumor volume direction distance least 2.5 cm inner table skull . Portions tumor plan treat due safety margin mark . 6 . Patients must ASA score 12 , Karnofsky score 70100 All tumor Types 1 . Clinical neuroradiological sign increase intracranial pressure . 2 . Significantly increased vascularization tumor preoperative MRangiogram digital subtraction angiography ( DSA ) . 3 . Tumor mass effect cause midline shift shift third ( 3rd ) ventricle 5 mm , even steroid therapy . 4 . The border tumor portion treat less 5mm away main branch brain vessel , venous sinus , pituitary gland cranial nerve . 5 . The tumor immediate proximity cystic formation . 6 . Recent ( less 2 week ) intracranial hemorrhage . 7 . Increased risk bleeding : platelet &lt; 100,000/mm3 , INR &gt; 1.3 coagulation disorder . 8 . Tumors presumably high risk bleed 9 . Oral anticoagulant thrombocyte aggregation suppression ( e.g . ASS ) stop least 5 day intervention . 10 . Contraindication MRexams , nonMRcompatible implant cardiac pacemaker . 11 . Clips implant sonication path target area . 12 . Operation implant dura patch , skull reconstruction polymethylmethacrylate ( PalacosTM ) , titan sonication path . 13 . Infratentorial ( i.e . cerebellar ) tumor . 14 . Contraindications MRcontrast agent steroid therapy 15 . Allergy local anesthesia . 16 . Uncontrolled arterial hypertension . 17 . Other life threaten disease . 18 . Severe uncontrolled systemic infection . 19 . Hypersensitivity contrast agent use study . 20 . Severely impaired renal function ( estimate glomerular filtration rate &lt; 30 mL/min/1.73 m2 ) dialysis . 21 . Inability give inform write consent . 22 . Alcohol drug abuse . 23 . Patients unreliable appear follow exam .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>FUS</keyword>
	<keyword>focus ultrasound</keyword>
	<keyword>functional brain disorder</keyword>
	<keyword>neuropathic pain</keyword>
	<keyword>movement disorder</keyword>
	<keyword>malignant brain tumor</keyword>
</DOC>